Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2011

01-07-2011 | Original Article

Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population

Authors: Shalu Jain, Sarita Agarwal, Parag Tamhankar, Prashant Verma, Gourdas Choudhuri

Published in: Indian Journal of Gastroenterology | Issue 4/2011

Login to get access

Abstract

Aim

To find out the association of common HFE mutations (viz., C282Y and H63D) with primary iron overload (PIL) in liver cirrhosis (CLD) patients of Indian origin.

Methods

Polymerase chain reaction-restriction fragment length polymorphism method was used for screening C282Y and H63D mutation in 496 CLD patients (hepatitis B virus associated cirrhosis (HBVc) = 74, hepatitis C virus associated cirrhosis (HCV) = 50, alcoholic cirrhosis with hepatitis (ALcW)  =  38, alcoholic cirrhosis without hepatitis (ALc) = 92, cryptogenic cirrhosis (CC) = 242) and 502 healthy controls. Transferrin saturation of >45 or serum ferritin of >300 ng/mL (males)/>200 ng/mL (females) with normal total exogenous iron intake was suggestive of PIL. Histological liver iron grading was done by Perl’s Prussian blue stain.

Results

Of 496 patients, 13 (2.6; 9 CC, 2 ALc, 1 HBVc, 1 AlcW) had PIL. However, only two (15.3) of 13 patients (1 CC and 1 HBVc) were positive for H63D heterozygous mutation. All the subjects were found to be C282Y wild type, except a single case of double heterozygous (C282Y/H63D) who however, did not have PIL. Overall frequency of H63D allele in patients and controls was not significantly different (5.95 and 4.58 respectively, p = 0.17). A highly significant H63D allele frequency (p  <  0.005) was observed in HBVc (10.82) and ALcW (11.84) groups but they were not associated with PIL.

Conclusion

The frequency of PIL, and the HFE gene mutaion (C282Y) are both rare in Indian patients and explain why hemochromatosis is a rare cause of liver cirrhosis in India. A highly significant H63D allele frequency in HBV and alcohol-related cirrhosis suggest a possible predisposing role for liver fibrosis of this allele.
Literature
1.
go back to reference Parkkila S, Niemelä O, Britton RS, et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology. 2001;121:1489–96.PubMedCrossRef Parkkila S, Niemelä O, Britton RS, et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology. 2001;121:1489–96.PubMedCrossRef
2.
go back to reference Fleming RE, Sly WS. Mechanism of iron accumulation in hereditary hemochromatosis. Ann Rev Physiol. 2002;64:663–80.CrossRef Fleming RE, Sly WS. Mechanism of iron accumulation in hereditary hemochromatosis. Ann Rev Physiol. 2002;64:663–80.CrossRef
3.
go back to reference Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.PubMedCrossRef Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.PubMedCrossRef
4.
go back to reference Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996;22:187–94.PubMedCrossRef Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996;22:187–94.PubMedCrossRef
5.
go back to reference Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34:275–8.PubMedCrossRef Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34:275–8.PubMedCrossRef
6.
go back to reference Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet. 1997;61:762–4.PubMedCrossRef Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet. 1997;61:762–4.PubMedCrossRef
7.
go back to reference Feder JN, Penny DM, Irrinki A, et al. The haemochromatosis gene product complexes with the transferring receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci. 1998;95:1472–7.PubMedCrossRef Feder JN, Penny DM, Irrinki A, et al. The haemochromatosis gene product complexes with the transferring receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci. 1998;95:1472–7.PubMedCrossRef
8.
go back to reference Garewal G, Das R, Ahluwalia J, Marwaha RK. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Eur J Haematol. 2005;74:333–6.PubMedCrossRef Garewal G, Das R, Ahluwalia J, Marwaha RK. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Eur J Haematol. 2005;74:333–6.PubMedCrossRef
9.
go back to reference Agarwal S. Tew.ari D, Arya V, et al. Status of HFE mutation in thalassemia syndromes in north India. Ann Hematol. 2007;86:483–5.PubMedCrossRef Agarwal S. Tew.ari D, Arya V, et al. Status of HFE mutation in thalassemia syndromes in north India. Ann Hematol. 2007;86:483–5.PubMedCrossRef
10.
go back to reference Dhillon BK, Das R, Garewal G, et al. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13:2956–9.PubMed Dhillon BK, Das R, Garewal G, et al. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13:2956–9.PubMed
11.
go back to reference Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. 1962;84:53–64. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. 1962;84:53–64.
12.
go back to reference EASL International Consensus conference on hemochromatosis. J Hepatol. 2000; 33:485–504. EASL International Consensus conference on hemochromatosis. J Hepatol. 2000; 33:485–504.
13.
go back to reference Kaur G, Rapthap CC, Xavier M, et al. Distribution of C282Y and H63D mutations in the HFE gene in healthy Asian Indians and patients with thalassemia major. Natl Med J India. 2003;16:309–10.PubMed Kaur G, Rapthap CC, Xavier M, et al. Distribution of C282Y and H63D mutations in the HFE gene in healthy Asian Indians and patients with thalassemia major. Natl Med J India. 2003;16:309–10.PubMed
14.
go back to reference Rees DC, Singh BM, Luo LY, Wickramasinghe S, Thein SL. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis. Ann N Y Acad Sci. 1998;850:490–4.PubMedCrossRef Rees DC, Singh BM, Luo LY, Wickramasinghe S, Thein SL. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis. Ann N Y Acad Sci. 1998;850:490–4.PubMedCrossRef
15.
go back to reference Thakur V, Guptan RC, Hashmi AZ, Sakhuja P, Malhotra V, Sarin SK. Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol. 2004;19:86–90.PubMedCrossRef Thakur V, Guptan RC, Hashmi AZ, Sakhuja P, Malhotra V, Sarin SK. Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol. 2004;19:86–90.PubMedCrossRef
16.
go back to reference Shukla P, Julka S, Bhatia E, Shah S, Nagral A, Aggarwal R. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis. Natl Med J India. 2006;19:20–3.PubMed Shukla P, Julka S, Bhatia E, Shah S, Nagral A, Aggarwal R. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis. Natl Med J India. 2006;19:20–3.PubMed
17.
go back to reference Panigrahi I, Ahmad F, Kapoor R, Sharma PK, Makharia G, Saxena R. Evidence for non-HFE linked hemochromatosis in Asian Indians. Indian J Med Sci. 2006;60:492–5.CrossRef Panigrahi I, Ahmad F, Kapoor R, Sharma PK, Makharia G, Saxena R. Evidence for non-HFE linked hemochromatosis in Asian Indians. Indian J Med Sci. 2006;60:492–5.CrossRef
18.
go back to reference Martinelli AL, Filho AB, Franco RF, et al. Liver iron deposits in hepatitis B patients: association with severity of liver disease but not with hemochromatosis gene mutations. J Gastroenterol Hepatol. 2004;19:1036–41.PubMedCrossRef Martinelli AL, Filho AB, Franco RF, et al. Liver iron deposits in hepatitis B patients: association with severity of liver disease but not with hemochromatosis gene mutations. J Gastroenterol Hepatol. 2004;19:1036–41.PubMedCrossRef
19.
go back to reference Moczulski DK, Grzeszczak W, Gawlik B. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin. Med Sci Moni. 2001;7:441–3. Moczulski DK, Grzeszczak W, Gawlik B. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin. Med Sci Moni. 2001;7:441–3.
20.
go back to reference Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K. Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol. 2004;83:654–7.PubMedCrossRef Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K. Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol. 2004;83:654–7.PubMedCrossRef
21.
go back to reference Ghaziani T, Alavian SM, Zali MR, et al. Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection. Hepatol Res. 2007;37:172–8.PubMedCrossRef Ghaziani T, Alavian SM, Zali MR, et al. Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection. Hepatol Res. 2007;37:172–8.PubMedCrossRef
22.
go back to reference Mah YH, Kao JH, Liu CJ, et al. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan. Liver Int. 2005;25:214–9.PubMedCrossRef Mah YH, Kao JH, Liu CJ, et al. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan. Liver Int. 2005;25:214–9.PubMedCrossRef
23.
go back to reference Kazemi-Shirazi LC, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis. Gastroenterology. 1999;116:127–34.PubMedCrossRef Kazemi-Shirazi LC, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis. Gastroenterology. 1999;116:127–34.PubMedCrossRef
24.
go back to reference Starcevic Cizmarevic N, Stepec S, Ristić S, et al. Hemochromatosis gene mutations in patients with alcoholic cirrhosis. Clin Genet. 2006;70:257–9.PubMedCrossRef Starcevic Cizmarevic N, Stepec S, Ristić S, et al. Hemochromatosis gene mutations in patients with alcoholic cirrhosis. Clin Genet. 2006;70:257–9.PubMedCrossRef
25.
go back to reference Lauret E, Rodríguez M, González S, et al. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol. 2002;97:1016–21.PubMedCrossRef Lauret E, Rodríguez M, González S, et al. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol. 2002;97:1016–21.PubMedCrossRef
26.
go back to reference Erhardt A, Maschner-Olberg A, Mellenthin C, et al. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 2003;38:335–42.PubMedCrossRef Erhardt A, Maschner-Olberg A, Mellenthin C, et al. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 2003;38:335–42.PubMedCrossRef
Metadata
Title
Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population
Authors
Shalu Jain
Sarita Agarwal
Parag Tamhankar
Prashant Verma
Gourdas Choudhuri
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 4/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0109-5

Other articles of this Issue 4/2011

Indian Journal of Gastroenterology 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.